Dimensional Fund Advisors
BOLD

Dimensional Fund Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

Dimensional Fund Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-806,830
Closed -$48.3M – 3432
2019
Q4 		$48.3M Buy
806,830
+24,451
+3% +$918K 0.02% 1476
2019
Q3 		$22M Buy
782,379
+86,451
+12% +$2.95M 0.01% 1952
2019
Q2 		$26.3M Buy
695,928
+58,392
+9% +$2.24M 0.01% 1895
2019
Q1 		$24.9M Buy
637,536
+73,489
+13% +$2.11M 0.01% 1929
2018
Q4 		$12M Buy
564,047
+394,602
+233% +$10.2M 0.01% 2246
2018
Q3 		$6.71M Buy
+169,445
New +$6.32M ﹤0.01% 2591

Dimensional Fund Advisors's BOLD Position: Q1 2020 in Review

Dimensional Fund Advisors sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 806,830 shares — an estimated $48.3M sold.

Dimensional Fund Advisors first reported a position in BOLD in Q3 2018 and held it in 6 quarters. The position peaked at $48.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Dimensional Fund Advisors reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 806,830 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $48.3M.
  • Dimensional Fund Advisors first reported a position in Audentes Therapeutics, Inc in Q3 2018 and held it in 6 quarters.
  • Dimensional Fund Advisors's Audentes Therapeutics, Inc position peaked at $48.3M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Dimensional Fund Advisors's 13F filing for Q1 2020, filed 14 May 2020.